CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL

NCT07294677 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

104

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma

Interventions

DRUG: Capivasertib
DRUG: Venetoclax
DRUG: Rituximab
DRUG: Blinatumomab
DRUG: Nelarabine
DRUG: mini-hyperCVD

Sponsor

University of Chicago